CITED1 Human Pre-designed siRNA Set A contains three designed siRNAs for CITED1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CITED2 Human Pre-designed siRNA Set A contains three designed siRNAs for CITED2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CITED4 Human Pre-designed siRNA Set A contains three designed siRNAs for CITED4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Citraconic anhydride (Methylmaleic anhydride) is a derivative of maleic anhydride. Citraconic anhydride is utilized to block the proteins amino groups reversibly, stabilizes certain enzymes and improves their catalytic performance, or to reverse the effects of formalin fixation in tissue sections. Citraconic anhydride is irritating for skin and eyes[1].

Citreoviridin-13C23 is 13C labeled 2,3-Pentanedione (HY-W012998). 2,3-Pentanedione is a common constituent of synthetic flavorings and is used to impart a butter, strawberry, caramel, fruit, rum, or cheese flavor in beverages, ice cream, candy, baked goods, gelatins, and puddings. 2,3-Pentanedione also occurs naturally as a fermentation product in beer, wine, and yogurt and is releasedduring roasting […]

Citric acid-18O is 18O-labeled Citric acid (HY-N1428) Citric acid is a natural preservative and food tartness enhancer. Citric acid induces apoptosis and cell cycle arrest at G2/M phase and S phase in HaCaT cells. Citric acid cause oxidative damage of the liver by means of the decrease of antioxidative enzyme activities. Citric acid causes renal […]

Citric acid-d4-1 is deuterated labeled Citric acid (HY-N1428) Citric acid is a natural preservative and food tartness enhancer. Citric acid induces apoptosis and cell cycle arrest at G2/M phase and S phase in HaCaT cells. Citric acid cause oxidative damage of the liver by means of the decrease of antioxidative enzyme activities. Citric acid causes […]

Citronellol-d6 is deuterated labeled Linalool (HY-N0368). Linalool is a natural monoterpene which is a competitive NMDA receptor antagonist. Linalool is orally active and crosses the blood-brain barrier. Linalool has anticancer, antibacterial, anti-inflammatory, neuroprotective, anxiolytic, antidepressant, anti-stress, cardioprotective, hepatoprotective, nephroprotective and pulmonary protective activities[1][2][3][4][5].

Citrulline-specific probe-rhodamine hydrate is a specific probe for citrulline (Citrulline) combined with a rhodamine fluorescent group. Citrulline is the hydrolysis product of arginine catalyzed by protein arginine deiminase (PAD). PAD is abnormally activated in many diseases, leading to increased citrulline levels. Citrulline-specific probe-rhodamine hydrate is a biological probe that can identify diseases showing abnormal increases […]

CIZ1 Human Pre-designed siRNA Set A contains three designed siRNAs for CIZ1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CK-963 is an activator for cardiac troponin (cTnC) with Ki of 11.5 μM. CK-963 exhibits activity in enhancing cardiac contractility in Sprague-Dawley rats[1].

CK1α degrader-1 (Compound 82) is an orally active CK1α degrader with a DC50 of 0.105 μM. CK1α degrader-1 can be used for the research of cancer[1].

CKAP2 Human Pre-designed siRNA Set A contains three designed siRNAs for CKAP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CKAP2L Human Pre-designed siRNA Set A contains three designed siRNAs for CKAP2L gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CKAP4 Human Pre-designed siRNA Set A contains three designed siRNAs for CKAP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CKAP5 Human Pre-designed siRNA Set A contains three designed siRNAs for CKAP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CKB Human Pre-designed siRNA Set A contains three designed siRNAs for CKB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

cKK-E15 is a peptide-lipid that can be used to formulate LNP3 with C14PEG2000, unmodified cholesterol, and DOPE[1].

CKLF Human Pre-designed siRNA Set A contains three designed siRNAs for CKLF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CKM Human Pre-designed siRNA Set A contains three designed siRNAs for CKM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CKMT1A Human Pre-designed siRNA Set A contains three designed siRNAs for CKMT1A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CKMT1B Human Pre-designed siRNA Set A contains three designed siRNAs for CKMT1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CKMT2 Human Pre-designed siRNA Set A contains three designed siRNAs for CKMT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CKS1B Human Pre-designed siRNA Set A contains three designed siRNAs for CKS1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CKS2 Human Pre-designed siRNA Set A contains three designed siRNAs for CKS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CL 5343 (5-Amino-1,3,4-thiadiazole-2-sulfonamide) is an inhibitor of human carbonic anhydrase B (HCA-B). CL 5343 can serve as a CA9 ligand to achieve the targeted delivery of maytansinoid to the cell membrane of SKRC52 renal cancer cells[1][2].

CL 5343 (5-Amino-1,3,4-thiadiazole-2-sulfonamide) is an inhibitor of human carbonic anhydrase B (HCA-B). CL 5343 can serve as a CA9 ligand to achieve the targeted delivery of maytansinoid to the cell membrane of SKRC52 renal cancer cells[1][2].

CL 5343 (5-Amino-1,3,4-thiadiazole-2-sulfonamide) is an inhibitor of human carbonic anhydrase B (HCA-B). CL 5343 can serve as a CA9 ligand to achieve the targeted delivery of maytansinoid to the cell membrane of SKRC52 renal cancer cells[1][2].

CL 5343 (5-Amino-1,3,4-thiadiazole-2-sulfonamide) is an inhibitor of human carbonic anhydrase B (HCA-B). CL 5343 can serve as a CA9 ligand to achieve the targeted delivery of maytansinoid to the cell membrane of SKRC52 renal cancer cells[1][2].

CL 5343 (5-Amino-1,3,4-thiadiazole-2-sulfonamide) is an inhibitor of human carbonic anhydrase B (HCA-B). CL 5343 can serve as a CA9 ligand to achieve the targeted delivery of maytansinoid to the cell membrane of SKRC52 renal cancer cells[1][2].

CL4H6 is a pH-sensitive cationic lipid. CL4H6 is the main component of lipid nanoparticles (LNPs), which can be used to target and deliver siRNA, and induces a potent gene-silencing response[1][2].

Claramine is a steroid polyamine with blood-brain barrier permeability. Claramine can regulate the properties of lipid membranes and protect cells from various biological toxins, including misfolded protein oligomers and biological protein-based toxins[1].

Claramine TFA is a steroidal polyamine. Claramine TFA can regulate the properties of lipid membranes and protect cells from various biological toxins, including misfolded protein oligomers and toxins derived from biological proteins[1].

Claramine TFA is a steroidal polyamine. Claramine TFA can regulate the properties of lipid membranes and protect cells from various biological toxins, including misfolded protein oligomers and toxins derived from biological proteins[1].

Clascoterone-d5 (Cortexolone 17 alpha-propionate-d5) is the deuterated analog of Clascoterone. Clascoterone is a topical and peripheral androgen antagonist[1][2][3].

CLASP1 Human Pre-designed siRNA Set A contains three designed siRNAs for CLASP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CLASP2 Human Pre-designed siRNA Set A contains three designed siRNAs for CLASP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

CLASRP Human Pre-designed siRNA Set A contains three designed siRNAs for CLASRP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.